Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score

BACKGROUND: Treatment by immune checkpoint blockade (ICB) provides a remarkable survival benefit for multiple cancer types. However, disease aggravation occurs in a proportion of patients after the first couple of treatment cycles. METHODS: RNA sequencing data was retrospectively collected. 6 tumour...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Si-Yang Maggie, Sun, Hao, Zhou, Jia-Ying, Zhang, Jia-Tao, Yin, Kai, Chen, Zhi-Hong, Su, Jian, Zhang, Xu-Chao, Yang, Jin-Ji, Zhou, Qing, Tu, Hai-Yan, Wu, Yi-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571398/
https://www.ncbi.nlm.nih.gov/pubmed/34715621
http://dx.doi.org/10.1016/j.tranon.2021.101254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571398/
https://www.ncbi.nlm.nih.gov/pubmed/34715621
http://dx.doi.org/10.1016/j.tranon.2021.101254

Ejemplares similares